The Scientific Advisory Committee (SAC) is composed of not less than five prominent scientists with expertise in various scientific disciplines relating to drug discovery and development, and/or to the specific reality of neglected diseases and patients. The committee operates independently of the Board of Directors and the Executive Team. The Board of Directors approves the selection of SAC members. The SAC has the mission to advise the Board of Directors on matters related to research and development and choice of projects as well as quality of the scientific production.

 

Nick White

Nick WhiteChair
Mahidol University, Thailand

Rashmi Barbhaiya

Rashmi H. Barbhaiya
Advinus Therapeutics, India

Kirana Bhatt

Kirana Bhatt
University of Nairobi, Kenya

Pierre-Etienne Bost

Pierre-Etienne Bost
Formerly with Institut Pasteur, France

Pierre Buffet

Pierre Buffet
Paris Descartes University and INTS, France

Carl Craft

J Carl Craft
Formerly with Medicines for Malaria Venture, Switzerland

Simon Croft

Simon Croft
London School of Hygiene and Tropical Medicine, UK

Andre Daher

Andre Daher
Farmanguinhos/FIOCRUZ, Brazil

Valérie Faillat

Valérie Faillat
Sanofi Espoir Foundation, France

Lisa Frigati

Lisa Frigati
Tygerberg Hospital, South Africa

Paul Herrling

Paul Herrling
Formerly with Novartis International AG, Switzerland

Dale Kempf

Dale Kempf
AbbVie, USA

Kita Kiyoshi

Kiyoshi Kita
Nagasaki University, Japan

Nilima A. Kshirsagar
Indian Council of Medical Research (ICMR), New Delhi, India

Murad Shahnaz

Shahnaz Murad
Formerly with Ministry of Health, Malaysia

Koert Ritmeijer

Koert Ritmeijer
Médecins Sans Frontières, Amsterdam

Nilanthi de Silva

Nilanthi de Silva
University of Kelaniya, Sri Lanka

Faustino Torrico

Faustino Torrico
Universidad Mayor de San Simon, Cochabamba

Muriel Vray

Muriel Vray
Institut Pasteur, France

John Westwick

John Westwick
Imperial College, London University, UK